Evidence map›Paper›PMID 36465648›Full record

ArticleFrontiers in endocrinology2022

Chlorogenic acid improves glucose tolerance, lipid metabolism, inflammation and microbiota composition in diabetic db/db mice.

Yongwang Yan, Qing Li, Ling Shen, Kangxiao Guo, Xu Zhou

Open access · goldFull text read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 90 citations in OpenAlex.

  1. Trial
  2. Plants (Basel, Switzerland) · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Optimization of Sweet Potato (Plants (Basel, Switzerland) · 2026
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Yongwang YanPharmaceutical College, Changsha Health Vocational College, Changsha, China.
Qing LiDepartment of Pathology, Changsha Health Vocational College, Changsha, China.
Ling ShenPharmaceutical College, Changsha Health Vocational College, Changsha, China.
Kangxiao GuoPharmaceutical College, Changsha Health Vocational College, Changsha, China.
Xu ZhouDepartment of Spleen, Stomach and Liver Diseases, Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine, Changsha, China.
Central South University · CNChangsha Hospital for Maternal and Child Health Care · CNHunan Academy of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Chronic and acute chlorogenic acid (CGA) can improve glucose tolerance (GT) and insulin sensitivity (IS). However, whether acute administration of CGA has beneficial effects on hepatic lipid metabolism and cecal microbiota composition remains unclear. Methods: In the current study, diabetic db/db mice were administered CGA or metformin, and db/m mice were used as controls to explore the effects of CGA on hepatic lipid metabolism, including fatty acid oxidation and transportation and triglyceride (TG) lipolysis and synthesis. Moreover, alterations in the inflammatory response and oxidative stress in the liver and gut microbe composition were evaluated. Results: The results showed that CGA decreased body weight and improved glucose tolerance and insulin resistance, and these effects were similar to those of metformin. CGA decreased hepatic lipid content by increasing the expression of Discussion: CGA can improve the antidiabetic effects, and microbes may critically mediate these beneficial effects.

Indexed as

Diabetes MellitusInsulin ResistanceMetforminMicrobiotaAnimalsChlorogenic AcidGlucoseInflammationLipid MetabolismMiceSuperoxidesTumor Necrosis Factor-alphaChlorogenic AcidGlucoseMetforminSuperoxidesTumor Necrosis Factor-alphachlorogenic acidhyperglycemiahyperlipidemiainflammationoxidative stress

Identifiers

PMID36465648
PMCPMC9714618
OpenAlexW4309604517

What OpenQuestion holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.